The potential place of chloroquine in the treatment of HIV-1-infected patients.
J Clin Virol. 2001;20:137-40.
Boelaert JR and Sperber K: Antiretroviral therapy. Lancet 1998; 352:
1224-1225. Boelaert JR, Sperber K, Piette J: Chloroquine exerts an additive
in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea.
AIDS Res Hum Retroviruses 1999;15:1241-7.
Boelaert JR, Yaro S, Augustijns P, Meda N, Schneider YJ, Schols D, Mols R,
De Laere EA, Van de Perre P. Chloroquine accumulates in breast-milk cells:
potential impact in the prophylaxis of postnatal mother-to-child transmission
of HIV-1. AIDS. 2001;15:2205-7.
Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, and Sperber K: Inhibition
of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison
with zidovudine. Clin Ther 1996;18:1080-1092.
Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G, Ito S, Buncic
RJ. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine
for rheumatic diseases. Lancet 2001; 358:813-814.
Lori F. Hydroxyurea and HIV: 5 years later - from antiviral to immuno-modulating
efffects. AIDS 1999; 13: 1433-1442.
Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, Gallo RC. Hydroxyurea
as an inhibitor of human immunodeficiency virus type I replication. Science
1994; 266:801-5.
Pal R, Gallo RC, Sarngadharan MG. Processing of the structural proteins
of human immunodeficiency virus type 1 in the presence of monensin and cerulenin.
Proc Natl Acad Sci U S A 1988;85:9283-6.
Savarino A, Gennero L, Chen HC, Serrano D, Malavasi F, Boelaert JR, Sperber
K. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum
of activity. AIDS. 2001;15:2221-9.
Savarino A, Gennero L, Sperber K, Boelaert JR. The anti-HIV-1 activity
of chloroquine. J Clin Virol. 2001;20:131-5.
Sperber K, Chiang G, Chen H, Ross W, Chusid E, Gonchar M, Chow R, and Liriano
O: Comparison of hydroxychloroquine with zidovudine in asymptomatic patients
infected with HIV-1. Clin Ther 1997;19:913-923.
Sperber K, Kalb TH, Stecher VJ, Banerjee R, and Mayer L: Inhibition of
human immunodeficiency virus type 1 replication by hydroxychloroquine in T
cells and monocytes. AIDS Res Hum Retroviruses 1993;9:91-98.
Sperber K, Louie M, Kraus T, Protier J, Sapira E, Lin S, Stecher V, and Mayer
L: Hydroxychloroquine treatment of patients with human immunodeficiency
virus type 1. Clin Ther 1995;17:622-636.
Tsai WP, Nara PL, Kung HF, and Oroszlan S: Inhibition of human immunodeficiency
virus infectivity by chloroquine. AIDS Res Hum Retroviruses 1990;6:481-489.